Dyslipidemia in Chronic Kidney Disease

被引：0

作者：

Sainani, Pardeep ^{[1
]}

Das, Bhagwan ^{[2
]}

Kumar, Santosh ^{[1
]}

Junejo, Abdul Manan ^{[1
]}

Memon, Rafia ^{[2
]}

Bai, Sapna ^{[1
]}

机构：

[1] Jinnah Postgrad Med Ctr, Dept Nephrol, Karachi, Pakistan

[2] Liaquat Univ Med & Hlth Sci, Dept Nephrol, Jamshoro, Pakistan

来源：

PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES | 2021年 / 15卷 / 09期

关键词：

Dyslipidemia; Chronic kidney disease (CKD); Cholesterol; Low density lipoprotein (LDL); High density lipoprotein (HDL); Hypertriglyceridemia; LIPID NEPHROTOXICITY; RENAL DYSFUNCTION; CHOLESTEROL; RISK; PROGRESSION; DIET;

D O I：

10.53350/pjmhs211592541

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objective: To determine the frequency for pattern of dyslipidemia in patients with chronic kidney disease. Study Design: Descriptive, cross-sectional Place and Duration of Study: Department of Nephrology, Jinnah Postgraduate Medical Centre (JPMC) from 26th December 2018to 28th June 2019. Methodology: One hundred and thirty-two patients were enrolled. Blood sample of 5 ml of each patient was taken and sent to the institutional pathology laboratory for measurement of lipid profile and pattern of dyslipidemia i.e. high cholesterol, low HDL, high LDL, hypertriglyceridemia was noted. Results: The mean age was 44.68 +/- 9.39 years and mean of duration of chronic kidney disease was 5.13 +/- 2.19 months. Seventy eight (59%) were males and 54 (41%) were females. Pattern of dyslipidemia i.e. high cholesterol, low HDL, high LDL and hypertriglyceridemia were documented in 89 (67.4%), 61 (46.2%), 65 (49.2%) and 37 (28.0%) patients respectively. Conclusion: Dyslipidemia is common among patients with chronic kidney disease is considerable. Regular evaluation of all chronic kidney disease patients for dyslipidemia and treatment need to be instituted.

引用

页码：2541 / 2543

页数：3

共 50 条

[1] DYSLIPIDEMIA IN CHRONIC KIDNEY DISEASE
Singh, Manish Kumar
Charan, V. D.
Parasher, Ishan
Pankaj, Pranjal
Kumar, Shrawan
Gupta, Kusum
Singh, Vindhyawasini Prasad
JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2013, 2 (36): : 6864 - 6875
[2] Dyslipidemia in Chronic Kidney Disease
Saland, J.
Satlin, L.
Ginsberg, H.
PEDIATRIC NEPHROLOGY, 2010, 25 (09) : 1960 - 1960
[3] Dyslipidemia in chronic kidney disease
Kowalski, Andrew
Krikorian, Armand
Lerma, Edgar V.
DM DISEASE-A-MONTH, 2015, 61 (09): : 396 - 402
[4] Dyslipidemia in patients with chronic kidney disease
Hager, Matthew R.
Narla, Archana D.
Tannock, Lisa R.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2017, 18 (01): : 29 - 40
[5] Dyslipidemia in children with chronic kidney disease
Saland, Jeffrey M.
Pierce, Christopher B.
Mitsnefes, Mark M.
Flynn, Joseph T.
Goebel, Jens
Kupferman, Juan C.
Warady, Bradley A.
Furth, Susan L.
KIDNEY INTERNATIONAL, 2010, 78 (11) : 1154 - 1163
[6] Treatment of dyslipidemia in chronic kidney disease
Stefanovic, V
Milojkovic, M
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2004, 27 (10): : 821 - 827
[7] Managing dyslipidemia in chronic kidney disease
Harper, Charles R.
Jacobson, Terry A.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (25) : 2375 - 2384
[8] Managing dyslipidemia in chronic kidney disease
Weiner, DE
Sarnak, MJ
JOURNAL OF GENERAL INTERNAL MEDICINE, 2004, 19 (10) : 1045 - 1052
[9] Epidemiology of dyslipidemia in chronic kidney disease
Iseki, Kunitoshi
CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2014, 18 (02) : 185 - 188
[10] Management of Dyslipidemia in Chronic Kidney Disease
Vedamurthy, Deepak
Sagheer, Usman
Patel, Akruti
Singh, Gurnoor
Kalra, Dinesh
CURRENT CARDIOVASCULAR RISK REPORTS, 2025, 19 (01)

← 1 2 3 4 5 →